Morgan Stanley’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34M | Buy |
2,478,470
+1,620,743
| +189% | +$22.2M | ﹤0.01% | 2279 |
|
|
2025
Q1 | $9.49M | Buy |
857,727
+90,427
| +12% | +$1M | ﹤0.01% | 3384 |
|
|
2024
Q4 | $8.17M | Sell |
767,300
-1,414,164
| -65% | -$15.1M | ﹤0.01% | 3570 |
|
|
2024
Q3 | $27.7M | Buy |
2,181,464
+342,758
| +19% | +$4.35M | ﹤0.01% | 2464 |
|
|
2024
Q2 | $30.9M | Buy |
1,838,706
+1,448,157
| +371% | +$24.3M | ﹤0.01% | 2201 |
|
|
2024
Q1 | $5.86M | Sell |
390,549
-519,699
| -57% | -$7.8M | ﹤0.01% | 3794 |
|
|
2023
Q4 | $13.7M | Buy |
910,248
+799,121
| +719% | +$12M | ﹤0.01% | 3665 |
|
|
2023
Q3 | $1.56M | Buy |
111,127
+48,174
| +77% | +$675K | ﹤0.01% | 4544 |
|
|
2023
Q2 | $652K | Sell |
62,953
-80,506
| -56% | -$833K | ﹤0.01% | 5084 |
|
|
2023
Q1 | $1.33M | Buy |
143,459
+94,310
| +192% | +$871K | ﹤0.01% | 4697 |
|
|
2022
Q4 | $436K | Buy |
49,149
+4,139
| +9% | +$36.7K | ﹤0.01% | 5310 |
|
|
2022
Q3 | $376K | Sell |
45,010
-38,266
| -46% | -$320K | ﹤0.01% | 5417 |
|
|
2022
Q2 | $681K | Buy |
83,276
+43,383
| +109% | +$355K | ﹤0.01% | 5258 |
|
|
2022
Q1 | $349K | Buy |
39,893
+17,519
| +78% | +$153K | ﹤0.01% | 5603 |
|
|
2021
Q4 | $214K | Sell |
22,374
-21,329
| -49% | -$204K | ﹤0.01% | 6026 |
|
|
2021
Q3 | $734K | Sell |
43,703
-29,897
| -41% | -$502K | ﹤0.01% | 5263 |
|
|
2021
Q2 | $1.13M | Buy |
73,600
+72,367
| +5,869% | +$1.11M | ﹤0.01% | 5010 |
|
|
2021
Q1 | $24K | Sell |
1,233
-15,945
| -93% | -$310K | ﹤0.01% | 6666 |
|
|
2020
Q4 | $310K | Buy |
17,178
+13,495
| +366% | +$244K | ﹤0.01% | 5354 |
|
|
2020
Q3 | $71K | Sell |
3,683
-87,348
| -96% | -$1.68M | ﹤0.01% | 5580 |
|
|
2020
Q2 | $2.38M | Buy |
91,031
+87,825
| +2,739% | +$2.29M | ﹤0.01% | 3434 |
|
|
2020
Q1 | $57K | Sell |
3,206
-24,803
| -89% | -$441K | ﹤0.01% | 5420 |
|
|
2019
Q4 | $935K | Buy |
28,009
+17,832
| +175% | +$595K | ﹤0.01% | 4582 |
|
|
2019
Q3 | $242K | Buy |
10,177
+4,759
| +88% | +$113K | ﹤0.01% | 5037 |
|
|
2019
Q2 | $194K | Sell |
5,418
-19,505
| -78% | -$698K | ﹤0.01% | 5039 |
|
|
2019
Q1 | $920K | Buy |
24,923
+9,856
| +65% | +$364K | ﹤0.01% | 4169 |
|
|
2018
Q4 | $649K | Sell |
15,067
-14,823
| -50% | -$638K | ﹤0.01% | 4614 |
|
|
2018
Q3 | $1.41M | Sell |
29,890
-6,155
| -17% | -$291K | ﹤0.01% | 4275 |
|
|
2018
Q2 | $1.79M | Buy |
36,045
+7,188
| +25% | +$358K | ﹤0.01% | 4174 |
|
|
2018
Q1 | $1.43M | Sell |
28,857
-4,555
| -14% | -$226K | ﹤0.01% | 4284 |
|
|
2017
Q4 | $1.24M | Buy |
33,412
+9,756
| +41% | +$363K | ﹤0.01% | 4397 |
|
|
2017
Q3 | $746K | Buy |
+23,656
| New | +$746K | ﹤0.01% | 4621 |
|